Shape-shifting agent targets harmful bacteria in the stomach

A new shape-shifting polymer can target and kill Helicobacter pylori bacteria in the stomach without killing helpful bacteria in the gut. Such a treatment could improve the digestive health of billions of people worldwide who contract H. pylori infections.

The antimicrobial agent morphs into a bacterial hole-puncher in the stomach's acidic environment and reverts to an amorphous, inactive structure when it reaches the higher pH environment of the small intestine.

Researchers at the University of Illinois and collaborators in China and at Vanderbilt University published their findings in the Proceedings of the National Academy of Sciences. The study leaders were Illinois professors Jianjun Cheng, a Hans Thurnauer Professor of Materials Science and Engineering, and Lin-Feng Chen, a professor of biochemistry.

"Fifty percent of the world population will have H. pylori infections in their lifetime," Cheng said. "It's a huge market that needs improved solutions, especially in developing countries. Our conformation-switchable polypeptide is the only therapy reported so far that can kill this bacteria at a specific pH range."

The standard treatment for H. pylori infections requires a cocktail of several antibiotics and an agent to reduce acidity in the stomach so that the antibiotics can work. This has the unfortunate side effect of killing off 65 to 80 percent of other bacteria in the digestive tract, Cheng said – bacteria crucial to maintaining digestive health, nutrient absorption and the immune system.

Cheng's group previously developed short protein chains that twist into a helical spiral, giving them a stiff, rodlike structure that can punch holes through bacterial membranes – a method of killing to which bacteria have little ability to develop resistance. With a few simple alterations to the side chains that branch out from the polymer backbone, the researchers were able to create a shape-shifting version of the hole-punching agent.

When in the pH range in most body tissues, the proteins are shapeless and limp, unable to get through cell membranes. But at acidic pH the stomach, they curl up into the spiral rod structures, allowing targeted killing of H. pylori.

"This is a very simple solution to this disease," Cheng said. "These materials become therapeutically effective in the stomach, but once they move to the small intestine – where you have a lot of good bacteria – the pH is neutral or slightly basic and the materials quickly lose their rigid structures. Then they are excreted from the body."

The researchers tested the drug on mice with H. pylori infections from several different cell lines, and found that the drug was effective against the H. pylori while maintaining populations of healthy gut bacteria. Since the mouse stomach has a slightly higher pH than the human stomach, the researchers believe it will be even more effective in the greater acidity of the human stomach, Chen said.

The researchers are performing tests in large animal models as the next step toward human studies. They have obtained a patent and are working toward commercializing the agent as well.

"Traditional treatment involves complicated drug designs and combinations. This drug is very easy to manufacture and scale up. It's just a polymer – a polypeptide chain with amino acid building blocks – and it's biodegradable," Cheng said.

Related Stories

Different changes to the microbial community of the stomach may explain why related conditions are associated with different risk levels and types of gastric tumor, according to a new study in PLOS Pathogens.

The long term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, is linked to a more than doubling in the risk of developing stomach cancer, finds research published online in the journal ...

Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization (WHO), about 750,000 patients die each year after developing the disease. The main cause is thought ...

Scientists at The University of Western Australia and Perth-based biotech Ondek Pty Ltd have revealed new insights into the function of an important bacterial protein in Helicobacter pylori, the bacterium that causes stomach ...

Half of the world's human population is infected with the stomach bacteria called Helicobacter pylori, yet it causes disease in only about 10 percent of those infected. Other bacteria living in the stomach may be a key factor ...

Researchers have uncovered a big clue as to why some of the bacteria that cause stomach ulcers pose a greater risk for serious problems like stomach cancer than others; it turns out these bacteria can exploit the surrounding ...

Recommended for you

Scientists have turned the smallest possible bits of diamond and other super-hard specks into "molecular anvils" that squeeze and twist molecules until chemical bonds break and atoms exchange electrons. These are the first ...

The concept of "from trash to treasure" holds true for the world of composting, where food waste is recycled into fertilizer for gardens. But what if compost could go beyond fertilizer? Now, one group reports in ACS Omega ...

Michigan State University scientists have produced experimental and modeling results that shed light on how a particular type of enzyme functions during spore formation, potentially advancing human health and disease research.

Using a state-of-the-art type of electron microscopy, an MIT-led team has discovered the structure of an enzyme that is crucial for maintaining an adequate supply of DNA building blocks in human cells.

Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties. Using the approach, scientists exchanged ...